secwatch.observer — SEC 8-K summary
======================================

Issuer:     LifeStance Health Group, Inc. (LFST)
CIK:        0001845257
Form:       8-K
Filed at:   2025-05-07T23:59:59+00:00
Accession:  0000950170-25-064745
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LifeStance Q1 revenue $333M (+11%), first positive net income as public company
-------------------------------------------------------------------------------

- Revenue $333M (+11% YoY); net income $0.7M vs net loss $21.1M in Q1 2024.
- Adjusted EBITDA $34.6M (+25% YoY); Center Margin $109.8M (33.0% of revenue).
- Clinician base grew to 7,535 (+10% YoY); visit volumes 2.1M (+10%).
- FY 2025 guidance reaffirmed: revenue $1.40B-$1.44B, Adj EBITDA $130M-$150M.
- Q2 2025 guidance: revenue $332M-$352M, Adj EBITDA $28M-$34M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1845257/000095017025064745/0000950170-25-064745-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1845257/000095017025064745/lfst-20250507.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-064745

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer